New patent for Boehringer Ingelheim drug JENTADUETO

By /
Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are ten patents…

Source

Biotechblog
Scroll to Top